KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Non Operating Investment Income (2018)

Historic Non Operating Investment Income for Arbutus Biopharma (ABUS) over the last 3 years, with Q2 2018 value amounting to $24.9 million.

  • Arbutus Biopharma's Non Operating Investment Income changed N/A to $24.9 million in Q2 2018 from the same period last year, while for Jun 2019 it was $24.9 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $24.9 million for FY2018, which is N/A changed from last year.
  • Latest data reveals that Arbutus Biopharma reported Non Operating Investment Income of $24.9 million as of Q2 2018.
  • Over the past 5 years, Arbutus Biopharma's Non Operating Investment Income peaked at $24.9 million during Q2 2018, and registered a low of $24.9 million during Q2 2018.